News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Pharmasset, Inc. (VRUS) Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell
July 13, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Schaefer Price, President & CEO of Pharmasset, Inc. (VRUS), will preside over the closing bell to celebrate the company's initial public offering on NASDAQ. Pharmasset, Inc. listed on Friday, April 27, 2007.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
May 5, 2026
·
4 min read
·
Heather McKenzie
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
April 28, 2026
·
5 min read
·
Andrea Park
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
April 17, 2026
·
5 min read
·
Nick Paul Taylor
